JIUYUAN GENE (02566) plans to repurchase H-shares worth up to 100 million yuan.

JIUYUAN GENE (02566) announced that on August 19, 2026, the Board of Directors resolved that, depending on market conditions, the company may continue to implement its H-share repurchase plan in accordance with the repurchase authorization. Accordingly, the company intends to use its own funds to repurchase H-shares in the open market during the period before the expiration of the repurchase authorization, with a maximum amount of RMB 100 million. The actual repurchase price for each H-share under each repurchase must not exceed 5.0% of the average closing price of the H-shares for the five trading days preceding each repurchase. The H-shares repurchased under the repurchase authorization may be cancelled or held as treasury shares. The company currently has strong cash flow and a stable overall financial condition, which can meet the demands of the company's continuous business development. The Board believes that the current share price does not fully reflect the company's intrinsic value and business prospects. Conducting share repurchases under the current circumstances will demonstrate the confidence of the company and the management team in its business development prospects and growth potential, ultimately benefiting the company and creating value for shareholders.